Media ReleasesSUDA Pharmaceuticals

View All SUDA Pharmaceuticals News


SUDA Pharmaceuticals - Suspension from Official Quotation


The securities of Suda Pharmaceuticals Ltd (‘SUD’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of SUD, pending the release of an announcement regarding a proposed licensing transaction and a capital raising.

For more information, download the attached PDF.

Download this document